Training, tools and resources to support the supply and safe administration of Take Home Naloxone for people who use opioids
This toolkit comprises training, tools, videos and resources related to the rollout and supply of Take Home Naloxone in Queensland.
Please note: to become authorised to possess and supply naloxone in Queensland, your employing entity needs to be registered as an Authorised Alternative Supplier (AAS) with Queensland Health's Healthcare Approval and Regulation Unit (HARU). To apply, carefully read and complete the following application form.
Organisations who are seeking approval are encouraged to use the endorsed eLearning module and Brief Education resources located within this toolkit as part of their application with HARU.
For more information on the Queensland approval process, email THN@health.qld.gov.au or call (07) 3708 5264.
For more information on the national rollout of the THN program click here.
To access the Pharmacy Programs Administrator (PPA) Portal click here.
Information for Hospital and Health Services (HHS) click here
Information for Non-Government Organisations (NGO) click here
Information for HHS Hospital Pharmacies click here
FRI. 28 OCT 2022, 4:07 PM
An information sheet on take home naloxone for Hospital and Health Services (HHS).
An information sheet on take home naloxone in the NGO context.
An information sheet on take home naloxone in the HHS Hospital Pharmacy context.
Instructions on how to administer Nyxoid® and details around identifying and responding to overdose.
Instructions on how to administer Prenoxad® and details around identifying and responding to overdose.
Application form to apply for general approval to supply naloxone to individuals under section 75 of the Medicines and Poisons Act 2019 (MPA).
A place to learn more about providing naloxone as part of the Take Home Naloxone program initiative, and how to register as or apply to be a provider.
A suite of resources on take home naloxone from the Pharmacy Programs Administrator (PPA).
This toolkit was developed through a collaboration between the Queensland Injector's Health Network (QuIHN), Metro North Mental Health - Alcohol and Drug Service, and the Queensland State Government's Department of Health.